Serine racemase (SR) is a pivotal enzyme in human biology, known for its unique ability to convert L-serine to its enantiomer, D-serine . This enzyme is encoded by the SRR gene located on chromosome 17 in humans . D-serine plays a crucial role as a neuronal signaling molecule by activating N-methyl-D-aspartate (NMDA) receptors in the brain .
Serine racemase is a pyridoxal 5’-phosphate (PLP)-dependent enzyme that catalyzes two primary reactions:
The enzyme’s activity is modulated by divalent cations such as magnesium and is allosterically activated by the magnesium/ATP complex . Key residues in the active site, including K56 and S84, play significant roles in PLP cofactor binding and activity modulation .
D-serine, produced by serine racemase, acts as a co-agonist of NMDA receptors, which are essential for synaptic plasticity, memory formation, and learning . Dysfunction of NMDA receptors has been implicated in various neurological disorders, including schizophrenia . Underexpression of serine racemase has been associated with the paranoid subtype of schizophrenia, and treatment with D-serine has shown potential in ameliorating some symptoms .
Recombinant human serine racemase is produced using advanced biotechnological methods to study its structure, function, and potential therapeutic applications. The recombinant form retains the enzyme’s native activity and is used in various research applications to understand its role in neurodegenerative diseases and to develop specific small molecule modulators .